Sequencing of SARS-CoV-2 variants
Our laboratories work alongside the South Tyrolean Health Authority to track and monitor variants of the SARS-CoV-2 virus.
Every Monday a special package arrives at the biomedical laboratories of Eurac Research. It contains 48 samples of viral RNA extracted from swabs that tested positive in South Tyrol. These samples are analyzed for possible mutant strains of SARS-CoV-2. Since January 2021, the local health authority has been engaged in monitoring for variants of the virus. This process involves more complex time and technology than the molecular analysis of swabs. In fact, to detect a variant, it is necessary to sequence, that is, to read the entire viral genome to identify possible differences and mutations. The Institute of Biomedicine of Eurac Research, equipped for this type of analysis, supports the Health Authority and every week analyzes part of the positive swabs on the territory.
Il nostro impegno e la nostra attività in 90 secondi
Other News & Events
14 October 2021
EPIC at the NOI project fair
The yearly EFRE project fair on October 22nd is the perfect opportunity to meet us, we are presenting EPIC at booth 13.
13 October 2021
CHRIS COVID-19 study protocol available to the scientific community
Available in Open Access, it represents a resource for researchers who want to replicate similar studies.
28 September 2021
New headquarters for the Institute for Biomedicine
From mid-2022, the Institute for Biomedicine will open its new headquarters in the NOI Techpark: the interview with our director Peter P. Pramstaller.
24 August 2021
Covid-19 in Val Gardena
Uno studio dell’Azienda Sanitaria e di Eurac Research individua diversi fattori legati alla positività a Covid-19. La ricerca si è svolta nella primavera 2020 in Val Gardena (BZ).
08 July 2021
Large genomic analysis highlights COVID-19 risk factors
A new worldwide study published in Nature reveals 13 loci that are strongly associated with infection or severe COVID-19. The Institute of Biomedicine contributed data from the CHRIS Covid 19 study ...
21 June 2021
We are Social
The Institute of Biomedicine opens its own social channel. Follow us on Twitter.